{"id":"https://openalex.org/W2808994737","doi":"https://doi.org/10.2337/db18-1135-p","title":"Oral Semaglutide Does Not Affect the Bioavailability of the Combined Oral Contraceptive Ethinylestradiol/Levonorgestrel","display_name":"Oral Semaglutide Does Not Affect the Bioavailability of the Combined Oral Contraceptive Ethinylestradiol/Levonorgestrel","alternate_titles":[],"publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2808994737","doi":"https://doi.org/10.2337/db18-1135-p","mag":"2808994737"},"language":"en","primary_location":{"id":"doi:10.2337/db18-1135-p","doi":"https://doi.org/10.2337/db18-1135-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1135-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2808994737"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052680276","display_name":"Andreas B. Jordy","orcid":"https://orcid.org/0000-0002-9329-3599","observed_orcids":["https://orcid.org/0000-0002-9329-3599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANDREAS B\u00d4RSTING JORDY","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036974871","display_name":"Astrid Breitschaft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ASTRID BREITSCHAFT","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036497949","display_name":"Erik Christiansen","orcid":"https://orcid.org/0000-0003-3562-9506","observed_orcids":["https://orcid.org/0000-0003-3562-9506"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ERIK CHRISTIANSEN","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048052863","display_name":"Charlotte Granhall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CHARLOTTE GRANHALL","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102324627","display_name":"Cilie W. Hansen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CILIE W. HANSEN","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074161271","display_name":"Azadeh S. Houshmand\u2010Oeregaard","orcid":"https://orcid.org/0000-0002-1595-5892","observed_orcids":["https://orcid.org/0000-0002-1595-5892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AZADEH HOUSHMAND-OREGAARD","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043297080","display_name":"Tine A. B\u00e6kdal","orcid":"https://orcid.org/0000-0002-1348-0352","observed_orcids":["https://orcid.org/0000-0002-1348-0352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TINE A. BAEKDAL","raw_affiliation_strings":["S\u00f8borg, Denmark, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00f8borg, Denmark, Berlin, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2033,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.86895366,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"67","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","score":0.7685999870300293,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","score":0.7685999870300293,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.16369999945163727,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.8899999856948853},{"id":"https://openalex.org/keywords/combined-oral-contraceptives","display_name":"combined oral contraceptives","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8970000147819519},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7990000247955322},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9639999866485596},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.921999990940094},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oral-semaglutide","display_name":"oral semaglutide","score":0.5690000057220459},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.41600000858306885},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9436867833137512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7139856219291687},{"id":"https://openalex.org/C2777956591","wikidata":"https://www.wikidata.org/wiki/Q415563","display_name":"Ethinylestradiol","level":4,"score":0.6994310617446899},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6960831880569458},{"id":"https://openalex.org/C2780186607","wikidata":"https://www.wikidata.org/wiki/Q416950","display_name":"Levonorgestrel","level":5,"score":0.6915852427482605},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6644059419631958},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6365742087364197},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6127974390983582},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5572924613952637},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5216724872589111},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46781492233276367},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.4453316628932953},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44041404128074646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4206293523311615},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34041541814804077},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3005545139312744},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.26058530807495117},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.1579083502292633},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.10992053151130676},{"id":"https://openalex.org/C2779076696","wikidata":"https://www.wikidata.org/wiki/Q1280670","display_name":"Family planning","level":4,"score":0.0848684310913086},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.0},{"id":"https://openalex.org/C2986817661","wikidata":"https://www.wikidata.org/wiki/Q185698","display_name":"Research methodology","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db18-1135-p","doi":"https://doi.org/10.2337/db18-1135-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db18-1135-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2054088567","https://openalex.org/W3152050242","https://openalex.org/W2929744948","https://openalex.org/W2065045192","https://openalex.org/W7160175618","https://openalex.org/W2944042183","https://openalex.org/W2903677519","https://openalex.org/W7163344067","https://openalex.org/W3137006723","https://openalex.org/W6920834238"],"abstract_inverted_index":{"Semaglutide":[0],"is":[1],"a":[2,111],"glucagon-like":[3],"peptide":[4],"(GLP-1)":[5],"analog":[6],"co-formulated":[7],"with":[8,67,142,179,184],"the":[9,27,31,99,102,151,170,203,206],"absorption":[10],"enhancer,":[11],"sodium":[12],"N-(8-[2-hydroxybenzoyl]":[13],"amino)":[14],"caprylate":[15],"(SNAC),":[16],"to":[17,72],"allow":[18],"oral":[19,24,33,68,143,146,180,198],"administration.":[20],"The":[21],"effect":[22,173],"of":[23,30,59,65,131,156,205],"semaglutide":[25,69,147,181,199],"on":[26],"pharmacokinetics":[28],"(PK)":[29],"combined":[32,207],"contraceptive":[34],"(OC)":[35],"ethinylestradiol":[36],"(EE;":[37],"0.03":[38],"mg)/levonorgestrel":[39],"(LN;":[40],"0.15":[41],"mg)":[42],"was":[43],"assessed":[44],"in":[45],"an":[46],"open-label,":[47],"one":[48],"sequence":[49],"crossover":[50],"trial.":[51],"Healthy":[52],"post-menopausal":[53],"females":[54],"(n=25)":[55],"received":[56],"8":[57,63],"days":[58,64],"OC":[60,66,138,141],"alone":[61,139],"and":[62,108,127,133,145,161,166,187],"(dose":[70],"escalated":[71],"steady":[73,117],"state":[74,118],"at":[75,80,86,92,116],"week":[76,79,85],"6:":[77],"1":[78,84],"3":[81],"mg":[82,88,94],"dose,":[83,89],"7":[87],"4":[90],"weeks":[91],"14":[93],"dose).":[95],"Primary":[96],"endpoints":[97,121],"were":[98,135,168,182],"areas":[100],"under":[101],"plasma":[103,153],"concentration\u2212time":[104],"curve":[105],"for":[106,137,164],"EE":[107,132,157,165],"LN":[109,134,167],"during":[110],"dosing":[112],"interval":[113,174],"(0\u221224":[114],"h)":[115],"(AUC0\u221224h,SS).":[119],"Secondary":[120],"included":[122],"other":[123],"PK":[124],"parameters,":[125],"safety":[126],"tolerability.":[128],"Total":[129],"exposure":[130,154],"similar":[136],"vs.":[140],"semaglutide,":[144],"did":[148,200],"not":[149,201],"affect":[150,202],"maximum":[152],"(Cmax,SS)":[155],"or":[158],"LN.":[159],"AUC0\u221224h,SS":[160],"Cmax,SS":[162],"ratios":[163],"within":[169],"predefined":[171],"no":[172],"(0.8\u22121.25)":[175],"(Figure).":[176],"Adverse":[177],"events":[178],"consistent":[183],"previous":[185],"trials":[186],"expected":[188],"GLP-1":[189],"receptor":[190],"agonist":[191],"class":[192],"effects.":[193],"These":[194],"data":[195],"indicate":[196],"that":[197],"bioavailability":[204],"OC.":[208],"Disclosure":[209],"A.":[210,218,247],"B\u00f4rsting":[211],"Jordy:":[212],"Employee;":[213,228,235,242,249,261],"Self;":[214,224,229,236,243,250,257,262],"Novo":[215,225,230,237,244,251,258,263],"Nordisk":[216,226,231,238,245,252,259,264],"A/S.":[217,227,232,239,246,253,260,265],"Breitschaft:":[219],"None.":[220],"E.":[221],"Christiansen:":[222],"Stock/Shareholder;":[223,256],"C.":[233],"Granhall:":[234],"C.W.":[240],"Hansen:":[241],"Houshmand-Oregaard:":[248],"T.A.":[254],"Baekdal:":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2808994737","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-06-29T00:00:00"}
